login
  Password reminder
Vascular News
Contact the editor Visit Vascular News Twitter feed Visit Vascular News Facebook page
 

Radiation study on mobile C-arm and aortic endografting


Friday, 24 Jun 2011 12:16
Stephan Haulon
Stephan Haulon


Stéphan Haulon, chief of Vascular Surgery Hôpital Cardiologique – CHRU Lille, France, presented data from a radiation study on mobile C-arm and aortic endografting at the CX Vascular Imaging Course.


Between April 2008 and October 2010, he told delegates, 301 patients were treated in the Advanced Endovascular Surgery theatre in the CHRU Lille using the mobile hybrid cath lab OEC 9900 Elite (GE Healthcare). The cases treated included 14 aorto-uni-iliac, 209 bifurcated (including iliac branch), 39 fenestrated, 15 branched and 24 thoracic aneurysms.

 

“Indirect dosimetric information was recorded for each patient. Cumulated dose – dose area product (DAP) – was calculated from imaging protocol as an estimator of energy imparted to the patient during the treatment. Fluoroscopy time and contrast media volume were proportional to procedure complexity,” he said.

 

In the literature, Haulon added, there are few DAP values for EVAR, and none are on fenestrated and branched grafts. “There are more reports on fixed rooms than in mobile C-arm operating rooms, and few cases, a maximum of 100, report a large range of DAP values,” he stated.

 

For the 209 bifurcated cases, Haulon said, mean fluoroscopy time was 10.2min and DAP was 3.1mGy.m2. In the 24 thoracic repair cases, fluoroscopy time was 8.2min and DAP was 2mGy.m2; in the aorto-uni-iliac procedures fluoroscopy time was 9.1min and DAP was 2.6mGy.m2. These results are similar or better than results seen in the literature, Haulon added.

 

DAP values and peak skin dose were confirmed by direct measurements on GAFCHROMIC XR RV3 films, which were placed underneath the patients registering total dose distribution over complete procedure.

 

In conclusion, Haulon said that the study found a consistency of DAP values in relation with procedure complexity.




Add New Comment

Most popular


ROADSTER trial studying new path to carotid revascularisation completes patient enrolment
Friday, 18 Jul 2014
The trial was the first of its kind to study the treatment of carotid artery stenosis by placing a stent via direct access to the common carotid artery in the neck in an entirely new minimally ... ROADSTER trial studying new path to carotid revascularisation completes patient enrolment

IMPROVE trial morphology analysis: The answer lies in the neck
Wednesday, 02 Jul 2014
An analysis of aneurysm morphology in the IMPROVE trial showed that for long aneurysm necks, mortality after endovascular aneurysm repair (EVAR) and open repair was very similar. Surprisingly, the ... IMPROVE trial morphology analysis: The answer lies in the neck

Endovascular-first strategy for aortoiliac lesions irrespectively of TASC category
Thursday, 17 Jul 2014
Two-year data from a prospective, multicentre study suggest that endovascular therapy with stenting may be considered the preferred first-line treatment option for aortoiliac lesions, irrespectively ... Endovascular-first strategy for aortoiliac lesions irrespectively of TASC category

Features


SPECT can predict cardiovascular mortality in elective aneurysm repair patients
Wednesday, 12 Mar 2014
Kimihiro Komori and Yosuke Inoue analyse the results of a study that concluded that preoperative pharmacologic stress myocardial perfusion SPECT is not only safe, but is also a useful method to ... SPECT can predict cardiovascular mortality in elective aneurysm repair patients

Hybrid techniques for the arch: are they effective and durable?
Monday, 17 Feb 2014
Piergiorgio Cao writes that despite the perioperative mortality risk, the late outcome of endovascular arch repair presents a low rate of aorta-related deaths and reinterventions and acceptable mid-... Hybrid techniques for the arch: are they effective and durable?

Profiles


Cliff Shearman
Thursday, 03 Jul 2014
A former president of the Vascular Society of Great Britain and Ireland, Cliff Shearman was ... Cliff Shearman

Andrew Holden
Tuesday, 11 Feb 2014
Andrew Holden has been involved in the investigation of several endovascular devices for the ... Andrew Holden

Cardiac Rhythm News Vascular News Cardiovascular News Interventional News Spinal News NeuroNews
BIBA Medical BIBA MedTech Insights CX Symposium ilegx
 
Password Reminder

BIBA Medical, 526 Fulham Road, Fulham, London, SW6 5NR.
TEL: +44 (0)20 7736 8788 FAX: +44 (0)20 7736 8283 EMAIL: 
info@bibamedical.com
© BIBA Medical Ltd is a company registered in England and Wales with company number 2944429.
VAT registration number 730 6811 50.
Site Map | Terms and Conditions